Clinical trial · Observational
Breast Cancer and Chemo-amennorhea
Etude Prospective Multicentrique de l'aménorrhée Chimio-induite et de sa réversibilité Dans le Cancer du Sein Chez Des Patientes préménopausées Recevant Une chimiothérapie Adjuvante ou néoadjuvante. Etude Améno-Chimio.
NCT01867229CI-TRIAL-00038033chemo-amenocompletedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Relation between chemotherapy and amennorhea
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| observational | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- FEC- TC
- description
- Fluorouracil- Epiadriamycine- Cyclophosphamide Taxotère-Cyclophosphamide
- interventionNames
- Other: observational
Primary outcomes (1)
- measure
- incidence and duration of the amenorrhea induced by chemotherapy
- timeFrame
- 5 years
Eligibility
Eligibility (as posted)
- Sex
- Female
Show eligibility criteria text
Inclusion Criteria: pre-menauposal breast cancer needed to be treat with chemotherapy - Exclusion Criteria: metastases menopausal \-
References
Publications (0)
Data not yet available
No reference posted for this study.